CEFMAX Drug Patent Profile
✉ Email this page to a colleague
When do Cefmax patents expire, and when can generic versions of Cefmax launch?
Cefmax is a drug marketed by Tap Pharm and is included in one NDA.
The generic ingredient in CEFMAX is cefmenoxime hydrochloride. There is one drug master file entry for this compound. Additional details are available on the cefmenoxime hydrochloride profile page.
Summary for CEFMAX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CEFMAX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CEFMAX
US Patents and Regulatory Information for CEFMAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tap Pharm | CEFMAX | cefmenoxime hydrochloride | INJECTABLE;INJECTION | 050571-002 | Dec 30, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tap Pharm | CEFMAX | cefmenoxime hydrochloride | INJECTABLE;INJECTION | 050571-003 | Dec 30, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tap Pharm | CEFMAX | cefmenoxime hydrochloride | INJECTABLE;INJECTION | 050571-001 | Dec 30, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
